TR200402670T4 - Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem - Google Patents

Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem

Info

Publication number
TR200402670T4
TR200402670T4 TR2004/02670T TR200402670T TR200402670T4 TR 200402670 T4 TR200402670 T4 TR 200402670T4 TR 2004/02670 T TR2004/02670 T TR 2004/02670T TR 200402670 T TR200402670 T TR 200402670T TR 200402670 T4 TR200402670 T4 TR 200402670T4
Authority
TR
Turkey
Prior art keywords
obesity
prophylaxis
treatment
compounds suitable
finding compounds
Prior art date
Application number
TR2004/02670T
Other languages
English (en)
Inventor
Hebebrand Johannes
Antel Jochen
Preuschoff Ulf
David Samual
Sann Holger
Weske Micjael
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of TR200402670T4 publication Critical patent/TR200402670T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

Obezitenin tedavisi ve/veya profilaksina uygun bilesiklerin bulunmasi için yöntem tarif edilmekte olup, burada memelilerde ve ve/veya insanlarda de novo lipogenez'in önlenmesi için incelenen bilesiklerin kabiliyeti tespit edilmektedir. Bulusa ayrica memelilerdeki de novo lipogenez'in önlenmesi yönünde kabiliyet sahip olan bilesiklerin obezitenin tedavisi ve/veya profilaksi olan ilaçlarin üretimi için kullanimi açiklanmaktadir.
TR2004/02670T 2000-07-20 2001-07-12 Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem TR200402670T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (de) 2000-07-20 2000-07-20 Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind

Publications (1)

Publication Number Publication Date
TR200402670T4 true TR200402670T4 (tr) 2004-11-22

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02670T TR200402670T4 (tr) 2000-07-20 2001-07-12 Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem

Country Status (27)

Country Link
EP (1) EP1307262B1 (tr)
JP (1) JP2004504053A (tr)
KR (1) KR100818827B1 (tr)
CN (1) CN1443085B (tr)
AR (1) AR028730A1 (tr)
AT (1) ATE278441T1 (tr)
AU (2) AU2001277534B9 (tr)
BR (1) BR0112547A (tr)
CA (1) CA2416647A1 (tr)
CZ (1) CZ2003156A3 (tr)
DE (2) DE10035227A1 (tr)
DZ (1) DZ3393A1 (tr)
ES (1) ES2230346T3 (tr)
HK (1) HK1057499A1 (tr)
HU (1) HUP0302309A3 (tr)
IL (2) IL153971A0 (tr)
MX (1) MXPA02012907A (tr)
NO (1) NO20030233L (tr)
NZ (1) NZ523960A (tr)
PL (1) PL201165B1 (tr)
PT (1) PT1307262E (tr)
RU (1) RU2268721C2 (tr)
SK (1) SK287607B6 (tr)
TR (1) TR200402670T4 (tr)
TW (1) TWI274157B (tr)
UA (1) UA74588C2 (tr)
WO (1) WO2002007821A1 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2395503C2 (ru) 2004-05-19 2010-07-27 Зольвай Фармасьютиклз Гмбх Лекарственные средства, содержащие n-сульфамоил-n'-арилпиперазины, предназначенные для профилактики или лечения ожирения и связанных с ним состояний
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2006127184A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
AR057570A1 (es) 2005-11-14 2007-12-05 Solvay Pharm Gmbh Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EA200870556A1 (ru) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
NZ579229A (en) 2007-01-25 2011-07-29 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
EP2340246A2 (en) 2008-06-23 2011-07-06 Janssen Pharmaceutica, N.V. Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
NZ702645A (en) * 2012-05-24 2016-08-26 Verva Pharmaceuticals Ltd A method of improving liver function
CN106770611B (zh) * 2016-12-22 2019-01-29 广西师范大学 一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
TJ286B (en) * 1992-10-29 2000-12-13 Genentech Inc A method for treatment or prevention of obesity
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
WO1998000130A2 (en) * 1996-06-28 1998-01-08 Ortho Pharmaceutical Corporation Anticonvulsant sulfamate derivatives useful in treating obesity
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
AU7753401A (en) 2002-02-05
DE50104023D1 (de) 2004-11-11
DE10035227A1 (de) 2002-01-31
PL201165B1 (pl) 2009-03-31
EP1307262A1 (de) 2003-05-07
KR20030022284A (ko) 2003-03-15
CN1443085B (zh) 2010-04-28
CA2416647A1 (en) 2003-01-20
CZ2003156A3 (cs) 2003-06-18
TWI274157B (en) 2007-02-21
AU2001277534B2 (en) 2005-09-29
SK612003A3 (en) 2003-06-03
RU2268721C2 (ru) 2006-01-27
UA74588C2 (en) 2006-01-16
AR028730A1 (es) 2003-05-21
CN1443085A (zh) 2003-09-17
KR100818827B1 (ko) 2008-04-01
ES2230346T3 (es) 2005-05-01
PL363518A1 (en) 2004-11-29
PT1307262E (pt) 2004-12-31
EP1307262B1 (de) 2004-10-06
NO20030233D0 (no) 2003-01-17
BR0112547A (pt) 2003-07-01
WO2002007821A1 (de) 2002-01-31
HK1057499A1 (en) 2004-04-08
SK287607B6 (sk) 2011-03-04
DZ3393A1 (fr) 2002-01-31
NZ523960A (en) 2004-12-24
ATE278441T1 (de) 2004-10-15
JP2004504053A (ja) 2004-02-12
NO20030233L (no) 2003-03-19
AU2001277534B9 (en) 2006-02-23
HUP0302309A2 (hu) 2003-11-28
HUP0302309A3 (en) 2005-06-28
MXPA02012907A (es) 2003-09-22
IL153971A (en) 2009-07-20
IL153971A0 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
TR200402670T4 (tr) Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
MXPA02011288A (es) Tioacetamidas substituidas.
GB0005251D0 (en) Therapeutic compounds
DE69919868D1 (de) Oregano zur behandlung interner parasiten und protozoen
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
BRPI0110506B8 (pt) uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
DE60231616D1 (de) Mittel zur verhinderung und behandlung von sexuell übertragenen krankheiten-i
RS8504A (en) Novel cyclohexil sulphones
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
ES2189206T3 (es) Beta-alcoxiacrilatos contra la malaria.
NO993360D0 (no) Anvendelse av pramipeksol ved behandling av "restless leg"- syndromet
NO20032597D0 (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
TR200002939T2 (tr) Paroksetin maleat
SI0758890T1 (tr)
MXPA03000313A (es) Uso de fosfato de estramustina en el tratamiento de metastasis osea.
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
DE60117541D1 (de) Candesartan zur Behandlung von Migräne
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
TR200003084T2 (tr) Paroxetine askorbat
ATE459372T1 (de) Vorbeugung und behandlung von p. gingivalis infektion
DK1299102T3 (da) Anvendelse af riluzol eller salte deraf til forebyggelse og behandling af adrenoleukodystrofi
ATE314854T1 (de) Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs